Skip to main content
Dicot Pharma AB logo

Dicot Pharma AB — Investor Relations & Filings

Ticker · DICOTBT ISIN · SE0011178458 LEI · 549300GX132RSE4OV407 SPGR Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing SPGR DICOTBT

About Dicot Pharma AB

https://www.dicotpharma.com/en/

Dicot Pharma AB is a pharmaceutical company dedicated to developing a new generation of drugs for treating sexual dysfunctions. The company's primary focus is its drug candidate, LIB-01, a potency agent intended for the treatment of erectile dysfunction and premature ejaculation. Dicot Pharma aims for LIB-01 to offer significant advantages over existing therapies, including a longer duration of effect, fewer side effects, and effectiveness for a broader patient population. The company has completed a Phase 2a proof-of-concept study for LIB-01, which demonstrated positive results in improving erectile function with a sustained effect.

Recent filings

No filings indexed yet

We are still gathering filings for Dicot Pharma AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.